较大肝癌局部消融的关键问题

doi:10.3969/j.issn.1672-5069.2014.03.004

Abstract

Lu Wei, Zhang Ningning. Key measures of local thermal ablation in treatment of patients with huge hepatocellular carcinoma[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(3): 234-237.

[1] Itoh S,Ikeda Y,Kawanaka H,et al. Efficacy of surgical microwave therapy in patients with unresectable hepatocellular carcinoma. Ann Surg Oncol,2011,18（13）:3650-3656.
[2] Bmix J,Sherman M. American Association for the Study of Liver Disease. Management of hepatocellular carcinoma：an update. Hepatology,2011,53（3）：1020-1022.
[3] Yin XY,Xie XY,Lu MD,et al. Percutaneous thermal ablation of medium and large hepatocellular carcinoma:long-term outcome and prognostic factors. Cancer,2009,115（9）:1914-1923.
[4] Ryosuke I,Toshihito S,Kozo I,et al. Percutaneous microwave coagulation therapy for hepatocellular carcinoma: Increased coagulation diameter using a new electrode and microwave generator. Oncol Reports,2010,24（3）:621-627.
[5] Nakazawa T,Kokubu S,Shibuya A,et a1.Radiofrequency ablation of hepatocellular carcinoma：correlation between local tumor progression after ablation and ablative margin.AJR,2007,188（2）：480-488.
[6] Seki T,Tamai T,Nakagawa T,et a1. Combination therapy with transcatheter arterial chemoembo1ization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer,2000,89（6）:1245-1251.
[7] Ng KK,Poon RT,Lo CM,et al. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.Gastrointest Surg,2008,12（1）:183-191.
[8] Shiomi H,Naka S,Sato K,et a1.Thoracoscopy-assisted magnetic resonance guided microwave coagulation therapy for hepatic tumors.Am J Surg,2008,195（8）:54-60.
[9] 刘建勇,陆伟. 超声引导下经皮微波消融治疗临近危险区域肝癌临床观察. 临床肝胆病杂志,2011,27（4）375-377.
[10] Ren H,Liang P,Yu X,et al. Treatment of liver tumours adjacent to hepatic hilum with percutaneous microwave ablation combined with ethano1 injection:A pilot study.Int J Hyperthermia,2011,27（3）:249-254.
[11] Nikfarjam M,Muralidharan V,Malcontenti-Wilson C,et a1.The apoptotic response of liver and colorectal 1iver metastases to focal hyperthermic injury. Anticancer Res,2005,25（2B）:1413-1419.
[12] 陆伟.整合医学理念对肝癌临床诊治的启示.中华消化杂志,2013,10（33）：658-660.

[1]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[2]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[3]	Zhu Jun, Ding Ying, Wang Shiqing, et al. Peripheral blood Th22 cells and plasma interleukin-22 level changes in patients with hepatocellular carcinoma after hepatectomy and administration of ulinastatin [J]. Journal of Practical Hepatology, 2019, 22(5): 720-723.
[4]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[5]	Qiu Jun, Wang Xueqing, Zhang Bo, et al. Percutaneous choledocholithotomy for the treatment of patients with intrahepatic bile duct stones [J]. Journal of Practical Hepatology, 2019, 22(5): 744-747.
[6]	Dai Qingyun, Wang Rundong, Jia Weidong. Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 561-564.
[7]	Ling Jing, Wang Juan. Clinical efficacy of gastroscopic lauromacrogol injection in treatment of patients with liver cirrhosis and esophageal varices [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 389-392.
[8]	Qiao Zhizhong. Value of contrast-enhanced ultrasonography in differential diagnosis of patients with focal nodular hyperplasia and hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 421-424.
[9]	Liu Wenbo, Zhang Jianye, Bao Jiwu. Analysis of risk factors for stone recurrence in patients with common bile duct stones after ERCP and EST therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 437-440.
[10]	Zhu Guangxi，Wen Liangzhi，Chen Dongfeng. Pathogenesis of non-alcoholic fatty liver disease-related hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 453-456.
[11]	Wang Huming, Fan Dongsheng, Xu Jie, Liu Xianfegn, Zhou Ning, Li Min, Bao Nana. Cancerous miRNA-30c levels affecting the survival of patients with hepatocellular carcinoma after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 248-251.
[12]	Xing Diankui, Cheng Jing. Clinical value of ¹⁸F-FDG PET/CT scan in patients with hepatocellular carcinoma and hepatic microvascular invasion [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 252-254.
[13]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Efficacy of transcatheter arterial chemoembolization and ultrasound-guided microwave ablation in the treatment of patients with hepatocellular carcinoma at special sites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 260-263.
[14]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[15]	Wang Zhaoxia, Guan Ke, Fu Sanxian, Wang Huijie. Early administration of enteral nutrition in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 272-275.

Key measures of local thermal ablation in treatment of patients with huge hepatocellular carcinoma

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments